Cataracts (Newton Laboratories, Inc.)
Welcome to the PulseAid listing for the Cataracts drug offered from Newton Laboratories, Inc.. This Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [Chemical/Ingredient],Plant Proteins [Chemical/Ingredient],Seed Storage Proteins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Newton Laboratories, Inc. |
| NON-PROPRIETARY NAME: | Arsenicum alb., Bryonia, Calc. fluor., Calendula, Causticum, Conium , Euphrasia, Hydrofluoricum acidum , Iodium, Ledum, Naphthalinum, Nat. mur., Nux vom., Phosphorus, Pulsatilla, Sepia, Silicea, Tellu |
| SUBSTANCE NAME: | ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CALCIUM FLUORIDE; CALENDULA OFFICINALIS FLOWERING TOP; CAUSTICUM; CONIUM MACULATUM FLOWERING TOP; EUPHRASIA STRICTA; HYDROFLUORIC ACID; IODINE; LEDUM PALUSTRE TWIG |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [Chemical/Ingredient],Plant Proteins [Chemical/Ingredient],Seed Storage Proteins [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | LIQUID |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2011-06-01 |
| END MARKETING DATE: | 0000-00-00 |
Cataracts HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cataracts from Newton Laboratories, Inc. |
| LABELER NAME: | Newton Laboratories, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 3([hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [h) |
| START MARKETING DATE: | 2011-06-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 55714-4588_000950e6-1774-b77d-e8c2-bd12a396e544 |
| PRODUCT NDC: | 55714-4588 |
| APPLICATION NUMBER: | |
Other ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CALCIUM FLUORIDE; CALENDULA OFFICINALIS FLOWERING TOP; CAUSTICUM; CONIUM MACULATUM FLOWERING TOP; EUPHRASIA STRICTA; HYDROFLUORIC ACID; IODINE; LEDUM PALUSTRE TWIG Pharmaceutical Manufacturers / Labelers:
